DRG CA 72-4 ELISA Kit Used in Winthrop University Study
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved tumor markers in patients with a variety of metastatic cancers during the course of treatment. This study was presented at the 2017 Gastrointestinal Cancers Symposium and will also be a featured poster at the Medlab Singapore Exhibition from April 3 – 5, 2017. You can find a link to the poster here.
The tumor-associated glycoprotein 72 (TAG-72) is a 48 kD mucine-like glycoprotein
complex that has been identified with the monoclonal murine antibody B72.3. Cancer antigen 72-4 (CA72-4) is an antigenic determinant of the TAG-72 glycoprotein which is recognized by B72.3 and CC-49 monoclonal antibodies. CA72-4 has been found to be elevated in a variety of human adenocarcinomas, with reported sensitivities of up 50% and overall specificity of over 95% and correlate with disease activity.
This study demonstrates that the DRG CA72-4 ELISA assay can be readily performed in a hospital laboratory and may serve as a useful adjunct to conventional tumor markers in the follow-up of a variety of metastatic cancers.
The DRG CA 72-4 ELISA Kit (EIA-5071) is CE marked and is for Research Use Only in the United States of America. For all sales inquiries, please contact Mr. Michael Martini at +1-973-564-7555 Ext. 204.
Latest posts by Gregory C. Guest (see all)
- DRG CA 72-4 ELISA Kit Used in Winthrop University Study - March 15, 2017
- DRG International to Exhibit at Medlab Dubai 2017 - February 3, 2017
- DRG at AACC: Takeaways - January 12, 2017
News and Updates
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more
We sat down with top members of the DRG International team at the AACC Convention 2016 in Philadelphia, PA, US and discuss innovation in the diagnostic testing field.read more
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel.read more
Chromogenics was first introduced to the public with the invention and patent for detecting E. coli bacteria by method of “chromogenic differentiation” culture media.read more
The DRG:HYBRID-XL fully automated random access analyzer is the perfect fit for medium or small laboratories. Its compact size can deliver to large demand and can be your primary machine to provide diagnostics to clients.read more
DRG International, Inc. recently exhibited at ENDO EXPO 2016, the largest meeting of endocrine practitioners and researchers, from April 1 – 3 at the Boston Convention & Exhibition Center in Boston, MA.read more
DRG® International, Inc. and DRG Instruments GmbH was proud to participate with our distributor Biomedix and with great success in Hospitalar 2016 In Expo-Centro Norte in Sao Paulo, Brazil, May 17-20, 2016read more